Skip to main content

Orbital Meningioma

  • Chapter
  • First Online:
  • 474 Accesses

Abstract

Orbital meningiomas can be divided into optic nerve sheath meningiomas, sphenoid wing meningiomas with orbital involvement, or primary orbital meningiomas. Orbital meningiomas comprise 34% of all primary brain tumors and 4% of all orbital tumors. Orbital meningiomas can cause proptosis, compression of the optic nerve, contents of the superior orbital fissure, cavernous sinus, and the temporal and frontal lobes. The proximity to vital neurological structures makes surgery demanding and challenging. “There is nothing in the whole realm of surgery more gratifying than the successful removal of a meningioma with subsequent perfect functional recovery” (Harvey Cushing, 1922).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Cushing H. The meningiomas (dural endotheliomas): their source, and favoured seats of origin. Brain. 1922;45:282–316.

    Google Scholar 

  2. Claus EB, Bondy ML, Schildkraut JM, et al. Epidemiology of intracranial meningioma. Neurosurgery. 2005;57(6):1088–95.

    PubMed  Google Scholar 

  3. MacCarty CS, Piepgras DG, Ebersold MJ. Meningeal tumors of the brain. In: Youmans JR, editor. Neurological surgery, vol. 5. 2nd ed. Philadelphia: WB Saunders; 1982. p. 2936–66.

    Google Scholar 

  4. Tan LT, Stewart CM, Sheerin F, et al. Ectopic orbital meningioma: fact or fiction? Orbit. 2017;36(3):144–6.

    PubMed  Google Scholar 

  5. Eddleman CS, Liu JK. Optic nerve sheath meningioma: current diagnosis and treatment. Neurosurg Focus. 2007;23(5):E4.

    PubMed  Google Scholar 

  6. Dutton JJ. Optic nerve sheath meningiomas. Surv Ophthalmol. 1992;37(3):167–83.

    CAS  PubMed  Google Scholar 

  7. Pandit R, Paris L, Rudich DS, et al. Long-term efficacy of fractionated conformal radiotherapy for the management of primary optic nerve sheath meningioma.Br J Ophthalmol. 2018. pii: bjophthalmol-2018-313135. https://doi.org/10.1136/bjophthalmol-2018-313135. [Epub ahead of print].

  8. Parker RT, Ovens CA, Fraser CL, et al. Optic nerve sheath meningiomas: prevalence, impact, and management strategies. Eye Brain. 2018;10:85–99. https://doi.org/10.2147/EB.S144345. eCollection 2018.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Cannon PS, Rutherford SA, Richardson PL, et al. The surgical management and outcomes for spheno-orbital meningiomas: a 7-year review of multi-disciplinary practice. Orbit. 2009;28:371–6.

    PubMed  Google Scholar 

  10. MacCarty CS. Meningiomas of the sphenoidal ridge. J Neurosurg. 1972;36(1):114–20.

    CAS  PubMed  Google Scholar 

  11. Morgenstern PF, Shah K, Dunkel IJ, et al. Meningioma after radiotherapy for malignancy. J Clin Neurosci. 2016;30:93–7.

    PubMed  PubMed Central  Google Scholar 

  12. Sadetzki S, Flint-Richter P, Ben-Tal T, et al. Radiation-induced meningioma: a descriptive study of 253 cases. J Neurosurg. 2002;97(5):1078–82.

    PubMed  Google Scholar 

  13. Cahan WG, Woodard HQ. Sarcoma arising in irradiated bone; report of 11 cases. Cancer. 1948;1(1):3–29.

    CAS  PubMed  Google Scholar 

  14. Godlewski B, Drummond KJ, Kaye AH. Radiation-induced meningiomas after high-dose cranial irradiation. J Clin Neurosci. 2012;19(12):1627–35.

    PubMed  Google Scholar 

  15. Mawrin C, Chung C, Preusser M. Biology and clinical management challenges in meningioma. Am Soc Clin Oncol Educ Book. 2015;35:e106–15.

    Google Scholar 

  16. Pećina-Šlaus N, Kafka A, Lechpammer M. Molecular genetics of intracranial meningiomas with emphasis on canonical Wnt signalling. Cancers (Basel). 2016;8(7). pii: E67.

    Google Scholar 

  17. Carroll RS, Zhang J, Black PM. Expression of estrogen receptors alpha and beta in human meningiomas. J Neuro-Oncol. 1999;42(2):109–16.

    CAS  Google Scholar 

  18. Hsu DW, Efird JT, Hedley-Whyte ET. Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg. 1997;86(1):113–20.

    CAS  PubMed  Google Scholar 

  19. Preston-Martin S. Descriptive epidemiology of primary tumors of the brain, cranial nerves and cranial meninges in Los Angeles County. Neuroepidemiology. 1989;8(6):283–95.

    CAS  PubMed  Google Scholar 

  20. Kuan AS, Chen YT, Teng CJ, et al. Risk of meningioma in patients with head injury: a nationwide population-based study. J Chin Med Assoc. 2014;77(9):457–62.

    PubMed  Google Scholar 

  21. Linsler S, Keller C, Urbschat S, et al. Prognosis of meningiomas in the early 1970s and today. Clin Neurol Neurosurg. 2016;149:98–103.

    PubMed  Google Scholar 

  22. Ostrom QT, Gittleman H, Fulop J, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro-Oncology. 2015;17(Suppl 4):iv1–iv62.

    PubMed  PubMed Central  Google Scholar 

  23. Yue NC, Longstreth WT Jr, Elster AD, et al. Clinically serious abnormalities found incidentally at MR imaging of the brain: data from the Cardiovascular Health Study. Radiology. 1997;202(1):41–6.

    CAS  PubMed  Google Scholar 

  24. Chamoun R, Krisht KM, Couldwell WT. Incidental meningiomas. Neurosurg Focus. 2011;31(6):E19. http://reference.medscape.com/medline/abstract/22133182.

    PubMed  Google Scholar 

  25. Yano S, Kuratsu J, Kumamoto Brain Tumor Research Group. Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience. J Neurosurg. 2006;105(4):538–43.

    PubMed  Google Scholar 

  26. Velnar T, Pregelj R, Limbaeck-Stokin C. Brain meningioma invading and destructing the skull bone: replacement of the missing bone in vivo. Radiol Oncol. 2011;45(4):304–9.

    PubMed  PubMed Central  Google Scholar 

  27. Shrivastava RK, Sen C, Costantino PD, et al. Sphenoorbital meningiomas: surgical limitations and lessons learned in their long-term management. J Neurosurg. 2005;103(3):491–7. http://reference.medscape.com/medline/abstract/16235682.

    PubMed  Google Scholar 

  28. Bikmaz K, Mrak R, Al-Mefty O. Management of bone-invasive, hyperostotic sphenoid wing meningiomas. J Neurosurg. 2007;107(5):905–12.

    PubMed  Google Scholar 

  29. Wright JE. Primary optic nerve meningiomas: clinical presentation and management. Trans Am Acad Ophthalmol Otolaryngol. 1977;83:617–25.

    CAS  Google Scholar 

  30. Changhong L, Naiyin C, Yuehuan G, et al. Primary intraosseous meningiomas of the skull. Clin Radiol. 1997;52(7):546–9.

    CAS  PubMed  Google Scholar 

  31. Chen TC. Primary intraosseous meningioma. Neurosurg Clin N Am. 2016;27(2):189–93.

    PubMed  Google Scholar 

  32. Crawford TS, Kleinschmidt-DeMasters BK, Lillehei KO. Primary intraosseous meningioma. Case report. J Neurosurg. 1995. Nov.;83(5):912–5.

    CAS  PubMed  Google Scholar 

  33. Chaves H, Bergamo Y, Paz S, et al. Sphenoid wing meningioma behavior on 11C-PiB and 18F-FDG PET. Clin Nucl Med. 2015;40(1):e81–2.

    PubMed  Google Scholar 

  34. Talacchi A, De Carlo A, D’Agostino A, et al. Surgical management of ocular symptoms in spheno-orbital meningiomas. Is orbital reconstruction really necessary? Neurosurg Rev. 2014;37(2):301–9; discussion 309–10.

    PubMed  Google Scholar 

  35. Simas NM, Farias JP. Sphenoid wing en plaque meningiomas: surgical results and recurrence rates. Surg Neurol Int. 2013;4:86.

    PubMed  PubMed Central  Google Scholar 

  36. DeMonte F, Tabrizi P, Culpepper SA, et al. Ophthalmological outcome after orbital entry during anterior and anterolateral skull base surgery. J Neurosurg. 2002;97(4):851–6.

    PubMed  Google Scholar 

  37. Bowers CA, Sorour M, Patel BC, et al. Outcomes after surgical treatment of meningioma-associated proptosis. J Neurosurg. 2016;125(3):544–50.

    PubMed  Google Scholar 

  38. Goodwin JW, Crowley J, Eyre HJ, et al. A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a Southwest Oncology Group study. J Neuro-Oncol. 1993;15(1):75–7.

    CAS  Google Scholar 

  39. Cossu G, Levivier M, Daniel RT, et al. The role of mifepristone in meningiomas management: a systematic review of the literature. Biomed Res Int. 2015;2015:267831.

    PubMed  PubMed Central  Google Scholar 

  40. Virchow R. Entwickelungsgescichte des Krebes. Virchows Arch. 1847;1:94.

    Google Scholar 

  41. Backer-Grøndahl T, Moen BH, Torp SH. The histopathological spectrum of human meningiomas. Int J Clin Exp Pathol. 2012;5(3):231–42.

    PubMed  PubMed Central  Google Scholar 

  42. Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–20.

    PubMed  Google Scholar 

  43. Kotecha RS, Jacoby P, Cole CH, et al. Morbidity in survivors of child and adolescent meningioma. Cancer. 2013;119(24):4350–7.

    PubMed  Google Scholar 

  44. da Silva CE, de Freitas PE. Large and giant skull base meningiomas: the role of radical surgical removal. Surg Neurol Int. 2015;6:113.

    PubMed  PubMed Central  Google Scholar 

  45. da Silva CE, Peixoto de Freitas PE. Recurrence of skull base meningiomas: the role of aggressive removal in surgical treatment. J Neurol Surg B Skull Base. 2016;77(3):219–25.

    PubMed  Google Scholar 

  46. Adegbite AB, Khan MI, Paine KW, et al. The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg. 1983;58(1):51–6.

    CAS  PubMed  Google Scholar 

  47. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957;20(1):22–39.

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97–109.

    PubMed  PubMed Central  Google Scholar 

  49. Terrier LM, Bernard F, Fournier HD, et al. Spheno-orbital meningiomas surgery: multicenter management study for complex extensive tumors. World Neurosurg. 2018;112:e145–56.

    PubMed  Google Scholar 

  50. Altay T, Patel BC, Couldwell WT. Lateral orbital wall approach to the cavernous sinus. J Neurosurg. 2012;116(4):755–63.

    PubMed  Google Scholar 

  51. Almeida JP, Omay SB, Shetty SR, et al. Transorbital endoscopic eyelid approach for resection of sphenoorbital meningiomas with predominant hyperostosis: report of 2 cases. J Neurosurg. 2018;128(6):1885–95.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bhupendra C. K. Patel .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Patel, B.C.K., Couldwell, W.T. (2019). Orbital Meningioma. In: Hwang, C.J., Patel, B.C., Singh, A.D. (eds) Clinical Ophthalmic Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-13558-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-13558-4_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-13557-7

  • Online ISBN: 978-3-030-13558-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics